Cite
Implant delivering hydroxychloroquine attenuates vaginal T lymphocyte activation and inflammation.
MLA
Chen, Yufei, et al. “Implant Delivering Hydroxychloroquine Attenuates Vaginal T Lymphocyte Activation and Inflammation.” Journal of Controlled Release : Official Journal of the Controlled Release Society, vol. 277, May 2018, pp. 102–13. EBSCOhost, https://doi.org/10.1016/j.jconrel.2018.03.010.
APA
Chen, Y., Traore, Y. L., Yang, S., Lajoie, J., Fowke, K. R., Rickey, D. W., & Ho, E. A. (2018). Implant delivering hydroxychloroquine attenuates vaginal T lymphocyte activation and inflammation. Journal of Controlled Release : Official Journal of the Controlled Release Society, 277, 102–113. https://doi.org/10.1016/j.jconrel.2018.03.010
Chicago
Chen, Yufei, Yannick L Traore, Sidi Yang, Julie Lajoie, Keith R Fowke, Daniel W Rickey, and Emmanuel A Ho. 2018. “Implant Delivering Hydroxychloroquine Attenuates Vaginal T Lymphocyte Activation and Inflammation.” Journal of Controlled Release : Official Journal of the Controlled Release Society 277 (May): 102–13. doi:10.1016/j.jconrel.2018.03.010.